{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:41:26Z","timestamp":1791362486614,"version":"4.3.1"},"reference-count":41,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2009,9,24]],"date-time":"2009-09-24T00:00:00Z","timestamp":1253750400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2010,2]]},"abstract":"<jats:p><jats:bold>BACKGROUND:<\/jats:bold> Invariant natural killer T cells (iNKT cells) may suppress graft\u2010versus\u2010host disease (GVHD) after allogeneic transplantation. The purpose of this study was to investigate the therapeutic potential of iNKT cells from major histocompatibility complex (MHC)\u2010mismatched donors for preventing GVHD after allogeneic bone marrow transplantation (BMT).<\/jats:p><jats:p><jats:bold>STUDY DESIGN AND METHODS:<\/jats:bold> In vitro, mouse iNKT cells were expanded with \u03b1\u2010galactosylceramide and interleukin (IL)\u20102 treatment. In the NKT\u2010treated group, lethally irradiated DBA\/2(H\u20102K<jats:sup>d<\/jats:sup>) mice were adoptively transferred with expanded iNKT, bone marrow (BM), and spleen cells (SCs) from C57BL\/6 (H\u20102K<jats:sup>b<\/jats:sup>) mice. Recipients in the control group were transferred only BM and SCs. The two groups were compared in survival, weight, histopathologic specimens, and serum cytokine analysis.<\/jats:p><jats:p><jats:bold>RESULTS:<\/jats:bold> In the iNKT\u2010treated group, 80% of mice survived past Day 60 after BMT, but all died within 38 days in the control group. The mice treated with iNKT did not exhibit signs of GVHD after Day 42 except for a change in fur color. There were higher IL\u20104 levels by Day 7 in serum of mice that received iNKT compared to those without iNKT treatment, while the interferon\u2010\u03b3 levels showed no significant difference between two groups. Levels of IL\u20102 and IL\u20105 increased by Day 21 only in iNKT\u2010treated mice.<\/jats:p><jats:p><jats:bold>CONCLUSION:<\/jats:bold> The results suggest that donor iNKT cells could alleviate GVHD symptoms and prolong survival after MHC\u2010mismatched allogeneic BMT, which may be associated with the maintenance in IL\u20104 levels. These findings indicate that the therapy based on iNKT cells from MHC\u2010mismatched donors has great potential in protection against GVHD after allogeneic hematopoietic stem cell transplantation.<\/jats:p>","DOI":"10.1111\/j.1537-2995.2009.02395.x","type":"journal-article","created":{"date-parts":[[2009,9,24]],"date-time":"2009-09-24T18:01:44Z","timestamp":1253815304000},"page":"407-417","source":"Crossref","is-referenced-by-count":30,"title":["Adoptive therapy by transfusing expanded donor murine natural killer T cells can suppress acute graft\u2010versus\u2010host disease in allogeneic bone marrow transplantation"],"prefix":"10.1111","volume":"50","author":[{"given":"Jie","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yana","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rufeng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huahua","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaicheng","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,2]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri2000"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.148.6.1687"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2007.06.003"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2008.57"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1365"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-03-077974"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2008.03.004"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.9.2754.009k25_2754_2759"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5699(00)01735-7"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri1309"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.25.022106.141711"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-4914(02)02325-0"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-006-6073-z"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.cellbio.24.110707.175359"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2008.03.004"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.21.120601.141057"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2008.03.018"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri2451"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.189.7.1073"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.175.2.1320"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.174.1.551"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.10.6242"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-04-1155"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2007.515"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704582"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.8.3230.bloodjournal8883230"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.9.5467"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.041608298"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(01)02623-9"},{"key":"e_1_2_8_31_2","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevImmunol.v28.i3.50"},{"key":"e_1_2_8_32_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.10.6579"},{"key":"e_1_2_8_33_2","doi-asserted-by":"crossref","first-page":"585","DOI":"10.4049\/jimmunol.155.2.585","article-title":"Polarized type 2 alloreactive CD4+ and CD8+ donor T cells fail to induce experimental acute graft\u2010versus\u2010host disease","volume":"155","author":"Krenger W","year":"1995","journal-title":"J. Immunol"},{"key":"e_1_2_8_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-472X(00)00677-9"},{"key":"e_1_2_8_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/35097097"},{"key":"e_1_2_8_36_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200420862"},{"key":"e_1_2_8_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2008.05.009"},{"key":"e_1_2_8_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri2343"},{"key":"e_1_2_8_39_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-06-165506"},{"key":"e_1_2_8_40_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.2000.00952.x"},{"key":"e_1_2_8_41_2","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.8.6.725"},{"key":"e_1_2_8_42_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2008.00730.x"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1537-2995.2009.02395.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1537-2995.2009.02395.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T19:09:52Z","timestamp":1697310592000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1537-2995.2009.02395.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["10.1111\/j.1537-2995.2009.02395.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1537-2995.2009.02395.x","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}